Literature DB >> 22777353

Histone arginine methylation keeps RUNX1 target genes in an intermediate state.

J Herglotz1, O N Kuvardina, S Kolodziej, A Kumar, H Hussong, M Grez, J Lausen.   

Abstract

The coordinated recruitment of epigenetic regulators of gene expression by transcription factors such as RUNX1 (AML1, acute myeloid leukemia 1) is crucial for hematopoietic differentiation. Here, we identify protein arginine methyltransferase 6 (PRMT6) as a central functional component of a RUNX1 corepressor complex containing Sin3a and HDAC1 in human hematopoietic progenitor cells. PRMT6 is recruited by RUNX1 and mediates asymmetric histone H3 arginine-2 dimethylation (H3R2me2a) at megakaryocytic genes in progenitor cells. H3R2me2a keeps RUNX1 target genes in an intermediate state with concomitant H3K27me3 and H3K4me2 but not H3K4me3. Upon megakaryocytic differentiation PRMT6 binding is lost, the H3R2me2a mark decreases and a coactivator complex containing WDR5/MLL and p300/pCAF is recruited. This leads to an increase of H3K4me3 and H3K9ac, which result in augmented gene expression. Our results provide novel mechanistic insight into how RUNX1 activity in hematopoietic progenitor cells maintains differentiation genes in a suppressed state but poised for rapid transcriptional activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777353     DOI: 10.1038/onc.2012.274

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

Review 1.  Stem cells, megakaryocytes, and platelets.

Authors:  Brenden W Smith; George J Murphy
Journal:  Curr Opin Hematol       Date:  2014-09       Impact factor: 3.284

Review 2.  Posttranslational modifications of RUNX1 as potential anticancer targets.

Authors:  S Goyama; G Huang; M Kurokawa; J C Mulloy
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

3.  Protein Arginine Methyltransferase 6 (Prmt6) Is Essential for Early Zebrafish Development through the Direct Suppression of gadd45αa Stress Sensor Gene.

Authors:  Xin-Xi Zhao; Yun-Bin Zhang; Pei-Li Ni; Zhi-Li Wu; Yuan-Chang Yan; Yi-Ping Li
Journal:  J Biol Chem       Date:  2015-10-20       Impact factor: 5.157

4.  Structural basis of arginine asymmetrical dimethylation by PRMT6.

Authors:  Hong Wu; Weihong Zheng; Mohammad S Eram; Mynol Vhuiyan; Aiping Dong; Hong Zeng; Hao He; Peter Brown; Adam Frankel; Masoud Vedadi; Minkui Luo; Jinrong Min
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

5.  RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation.

Authors:  Olga N Kuvardina; Julia Herglotz; Stephan Kolodziej; Nicole Kohrs; Stefanie Herkt; Bartosch Wojcik; Thomas Oellerich; Jasmin Corso; Kira Behrens; Ashok Kumar; Helge Hussong; Henning Urlaub; Joachim Koch; Hubert Serve; Halvard Bonig; Carol Stocking; Michael A Rieger; Jörn Lausen
Journal:  Blood       Date:  2015-04-24       Impact factor: 22.113

Review 6.  The role of chromatin modifiers in normal and malignant hematopoiesis.

Authors:  Jill S Butler; Sharon Y R Dent
Journal:  Blood       Date:  2013-01-02       Impact factor: 22.113

Review 7.  'Enhancing' red cell fate through epigenetic mechanisms.

Authors:  Marlies P Rossmann; Leonard I Zon
Journal:  Curr Opin Hematol       Date:  2021-05-01       Impact factor: 3.284

8.  PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1.

Authors:  Lucas Schneider; Stefanie Herkt; Lei Wang; Christine Feld; Josephine Wesely; Olga N Kuvardina; Annekarin Meyer; Thomas Oellerich; Björn Häupl; Erhard Seifried; Halvard Bonig; Joern Lausen
Journal:  Oncogenesis       Date:  2021-05-17       Impact factor: 7.485

Review 9.  Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia.

Authors:  Kate H Brettingham-Moore; Phillippa C Taberlay; Adele F Holloway
Journal:  Front Immunol       Date:  2015-09-29       Impact factor: 7.561

10.  The T-cell oncogene Tal2 Is a Target of PU.1 and upregulated during osteoclastogenesis.

Authors:  Nadine Courtial; Christian Mücke; Stefanie Herkt; Stephan Kolodziej; Helge Hussong; Jörn Lausen
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.